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Abstract 
Both poor nutrition and psychological status are independent risk factors for severe side effects of cancer treatment, and have 
impact on after treatment recovery. It has also been observed that psychotherapy may lead to health behavior changes such as 
healthier diet, which may improve general health. However, the complex interplay between psychotherapy and nutrition, 
achieving a synergetic effect on QoL and general health, is far from being understood. The main objective of this article will be 
to describe how and why a multicomponent, psychotherapy and dietary intervention should be implemented and explain some of 
the mechanisms that confer its effectiveness. 
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1. Introduction 
In Europe, 3.2 million people are diagnosed with cancer every year and this figure is expected to further increase 
due to the ageing population (Ferlay et al., 2007). Accounting for about one third of deaths of Europeans, cancer has 
become the second most common cause of death (GLOBOCAN, 2011), with almost every family being affected in 
some way by cancer. Lacking a therapeutic breakthrough in most cancers, especially in the rarer forms, cancer 
remains a leading cause of disability and death in Europe (Travado et al., 2012). 
In spite of intensive research, the causes of malignant neoplastic processes are only partly known today, and, 
according to the present state of knowledge, a multifactorial genesis must be assumed (Hürny, 1990). Due to the 
complexity of the disease and the pluridimensional impact it has on the life of the patient, cancer, and cancer 
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interventions are now thought to fit within a biopsychosocial model of health and illness (Sarafino, 2006), rather 
than the old traditional biomedical model of healthcare. The biopsychosocial models of health and illness address 
biological (function, structure, physical characteristics), psychological (stress, mental health, quality of life), 
behavioral (health behaviors, compliance) and social (social support, community influences) factors that interact 
with one another, and affect overall health. Based on the biopsychosocial models, the different supportive cancer 
care programs emerging from the vast line of research on this topic prove the effectiveness of different 
multicomponent biobehavioral interventions. The Lancet report has had a relatively brief history (Andersen, 1992), 
but even some of the earliest well-documented outcome studies such, as Gordon et al.’s (1980) had an intervention 
with three components: education (teaching about the medical system, disease and treatment side effects, relaxation 
training to reduce emotional distress), counselling (support and ventilation of feelings, issue clarification, problem 
solving and social support), and environmental change (referral for additional services and advocacy to health care 
personnel). As expected, studies show that these types of multicomponent interventions add substantial quality of 
life compared to the medical treatment alone. Most cancer therapies, even the conventional medical treatments, are 
empirical. Therefore, it is only natural that the multidisciplinary interventions which focus on positive biobehavioral 
outcomes should aim to incorporate all necessary components that have a scientifically proven impact on quality of 
life. The term quality of life itself seems to advocate such an approach, because it defines a multidimensional 
construct that includes functional ability (activity), psychological functioning (e.g., mental health), social 
adjustment, and disease- and treatment-related symptoms (Andersen et al,. 1994).  
Evidence suggests that health behavior interventions such as dietary intervention and simple physical activity 
represent efficient and cost-effective adjuvant therapies. Both poor nutrition status and psychological status are 
independent risk factors for severe side effects of cancer treatment, and have impact on the recovery of physical 
performance status in patients after treatment (Tian et al., 2007). More so, nutritional intervention is probably about 
to be considered as a supportive measure within the global oncology strategy. It is already known that, in curative 
oncology care, it contributes to reduced postoperative infection rate, better control of cancer-related symptoms, 
shortened length of hospital stay and improved tolerance to treatment (Caro et al., 2007).  
It has been observed that psychotherapy may lead to health behavior change, such as healthier diet; in fact, in a 
couple of studies (e.g., Fawzy et al., 1993), this being the indirect mechanism proposed in order to explain the 
survival advantages of patients attending psychotherapy. Some of the pathways through which diet influences major 
components of the biobehavioral model (Andersen et al., 1994), such as immune functioning and general 
compliance, leading (directly or indirectly) to better disease outcomes, have also been described. However, the 
complex interplay between psychotherapy and dietary interventions, achieving a beneficial synergetic effect on QoL 
and general health, is far from being understood. For example, the current psycho-oncology literature has mostly 
overlooked the direct effects of nutrition on mental status, mood states and many psychological symptoms.  
2.  Psychotherapy and nutritional therapy in cancer care: an overview 
Undoubtedly, the emotional impact of cancer diagnosis is devastating and can be associated with shock, disbelief, 
anger, anxiety, depression and difficulty in performing regular activities. A similar response occurs at each 
transitional point of the disease, that of beginning treatment, recurrence, treatment failure and disease progression 
(Uitterhoeve et al., 2004). The distressing impact of cancer was long ago acknowledged by the literature and hence 
provided a powerful incentive for the growth of psycho-oncology research, different psychosocial interventions and 
numerous supportive cancer care programs, some of which have already proven their effectiveness.   
However, once diagnosed with cancer, patients will always confront with numerous stressful events in their lives 
which may cause negative emotional reactions, and that some of these reactions may be of high clinical severity 
(Smith et al., 1999). The most frequently met disorders are anxiety and depression. Up to 58% of patients show 
symptoms of depression, while up to 38% suffer from major depression (Massie, 2004). These figures fluctuate of 
course depending on the circumstances, for example, among cancer patients in palliative care, a higher percentage of 
58%-76% are shown to suffer from depression (Stiefel et al., 2001). Anxiety is another major disruptive factor that 
affects quality of life and it may cause deterioration of patients’ general functionality. The prevalence of morbid 
anxiety is higher among cancer patients, compared to population unaffected by chronic disease (Wells et al., 1988). 
Anxiety affects approximately 47% of patients undergoing chemotherapy (Hipkins et al., 2004).  
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The above studies regarding emotional reactions and metal disorders show solid proof that psychological 
intervention is not to be seen as a luxury, but as a necessity. Meta-analyses (Devine & Westlake, 1995; Sheard & 
Maguire, 1999; Williams & Dale, 2006) and recent reviews (Newell et al., 2002; Uitterhoeve et al., 2004) centred 
upon cancer and depression have presented a wide range of psychotherapeutic interventions that that are shown to 
be helpful for cancer patients. Other meta-analyses suggest an even more powerful effect of psychological 
interventions on anxiety (Sheard & Maguire, 1999; Osborn et al., 2006). 
Aside from psychological interventions, nutritional therapy through healthy eating habits can also help patients 
deal with the effects of cancer and its treatment, both physically and mentally. Nutritional therapy helps restore 
digestive health, prevents malnutrition and provides dietary recommendations during treatment. The goal is to help 
patients continue cancer treatment, working together in close proximity: the patient, oncologist, nutritionist and 
psychotherapist, as a team, will allow for a fully integrated approach in treating cancer. The nutritionist and the 
psychotherapist can also provide information about health behaviours to the patient’s family in order to achieve a 
healthier life at home. According to the highly respected World Cancer Research Fund Global Network (WCRF) 
some cancer treatments work better when patients are well nourished and get enough kilocalories and protein in a 
diet, the right type of fatty acids and the adequate amount of high quality carbohydrates. Well nourished patients 
may have a better prognosis (chance of recovery) and improved quality of life.  
The brain is more sensitive to food intake than any other organ in the body. Blood circulation, blood sugar 
regulation and the level of neurotransmitters in the brain have all kind of effects on the brain. Certain phytonutrients 
modulate this level of neurotransmitters into the blood stream and finally, by a good balance, may have a profound 
impact on mood states (Benton et al., 1995; Kaplan et al., 2004).  
Over the past few years a significant number of reviews and studies on the clinical effectiveness of nutrient 
treatments for depression, anxiety disorders, aggressive feelings and sleep disturbance have been published (Ross, 
2009; Saeed et al., 2007; Nemets et al., 2002; Puri et al., 2002; Hamazaki et al., 2002; Brown & Gerbarg, 2001; 
Weeks, 2009; Cauffield & Forbes, 1998). These have reviewed data associated with a number of treatments, 
including St. John’s Wort, S-adenosyl-methionine (SAM-e), B vitamins, inositol, choline, kava, omega-3 fatty 
acids/fish extracts, valerian, lavender, melatonin, passionflower, gamma aminobutyric acid (GABA), theanine, 
tryptophan and 5-hydroxytryptophan (5-HTP) (Lakhan et al., 2010). The combination of nutrients at even modest 
levels can boost immunity very effectively. Cancer patients’ immune strength is dependent on an optimal intake of 
vitamins and minerals (Good & Lorenz, 1988). Since no nutrients work in isolation (see food synergy) a good high 
dose of vitamins and minerals from fresh vegetables and fruits, whole grain / pulses, plus ground seeds, lentils, 
beans and fish are usually prescribed by nutritionists in order to enhance immune functioning.   
Cancer patients with B factor (B vitamins group) deficiency are more prone to suffer from common symptoms 
like anxiety, inability to concentrate, inner tension, tendency to stress, emotional instability, anger or aggressive 
feelings. This kind of symptomatology can be augmented in cancer patients by the lack or imbalance of fatty acids 
known as OMEGA-3 and OMEGA-6 that are so close involved in optimal brain function. Cancer and cancer 
treatments may affect taste, smell, appetite and the ability to eat enough food or to absorb the right nutrients and this 
may lead to malnutrition. Furthermore, appetite loss, or anorexia, is the most frequent and the most important 
contributory factor in nutritional deterioration among cancer patients, resulting from several intricately linked 
physiopathological and psycho-behavioral mechanisms. However, these multifaceted, dual-natured (psychological 
and physiological) conditions like anorexia, malnutrition, cancer-related fatigue, impaired body image and pain are 
not the only advocacies for combining nutrition with psychotherapy in supportive cancer care. The patient’s general 
well-being, quality of life, functional adjustment and even disease course are the major variables that are the focus 
of interdisciplinary interventions, as pointed out in the biopsychosocial model (Engel, 1980; see Adler, 2009) or the 
biobehavioral model (Andersen et al., 1994). The single omission the second model makes is that whilst it 
acknowledges the impact of psychological intervention / psychotherapy on health behaviours (like nutrition), it does 
not point out that health behaviours can heavily impact the course and outcome of psychotherapy.    
Previous reviews of the literature have shown that psychotherapy and psycho-social interventions may be 
beneficial to cancer patients by raising awareness and increasing their knowledge about their disease and treatment 
(Fawzy et al., 1995; Devine & Westlake, 1995; Burke & Kissane, 1998), by alleviating or diminishing distress 
(Gurevich et al., 2002), by improving their emotional adjustment, coping skills and over-all quality of life (Rimer et 
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al., 1985; Meyer & Mark, 1995; Fawzy et al., 1995; Devine & Westlake, 1995; Burke & Kissane, 1998; Andersen, 
2002), by improving  mood, perceived meaning of life, and self-efficacy (Shapiro et al., 2001), by strengthening 
their satisfaction with the conventional medical treatment and care (Rimer et al., 1985; Meyer & Mark, 1995) and 
their compliance towards it (Rimer et al., 1985), by ameliorating their physical health and functional adjustment 
(Fawzy et al., 1995; Devine & Westlake, 1995; Burke & Kissane, 1998) and by reducing treatment-related, disease-
related, and conditioned symptoms (Rimer et al., 1985; Devine & Westlake, 1995; Meyer & Mark, 1995), by 
optimizing health behaviors, biologic responses (Andersen, 2002; Andersen et al., 2004) and immune system 
functioning (Fawzy et al., 1995). Although this has become probably one of the most controversial subjects in the 
psycho-oncology literature, four (Spiegel et al., 1989; Fawzy et al., 1993; Richardson et al., 1990; Kuchler et al., 
1998) out of eight (Linn et al., 1982; Cunningham et al., 1998; Ilnyckyj et al., 1994; Goodwin et al., 2001) most 
important randomized clinical studies have indicated that psychotherapy is associated with increasing the length of 
survival of breast cancer, gastrointestinal cancer, malignant melanoma and lymphoma patients.   
3.  Conclusions 
The aims of nutritional therapy in cancer care, aided by psychotherapy, are to offer support during medical 
treatment and increase the compliance towards it, to minimize side effects, to adjust any nutritional deficiencies, to 
reduce the risk of infection by modulating immune system indicators, to improve quality of life, to maintain weight 
and to work on prevention of secondary cancers. 
Nutrition should plays a major role in cancer care as 20—40% of cancer related deaths may result from 
nutritional problems rather than the disease itself (National Cancer Institute, US National Institutes of Health). The 
European Commission has established that a quarter of a million lives could be saved each year through dietary 
changes alone. According to the British Cancer Research Campaign “At least three out of four of all cancers are 
potentially preventable, but will only be avoided if the messages get through at a young age”. 
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